[Federal Register Volume 69, Number 50 (Monday, March 15, 2004)]
[Notices]
[Pages 12179-12180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-5775]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importation of Controlled Substances; Notice of Application

    Pursuant to section 1008 of the Controlled Substances Import and 
Export Act (21 U.S.C. 958(1)), the Attorney General shall, prior to 
issuing a registration under this section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
registration under section 1002(a) authorizing the importation of such 
a substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with section 1301.34 of Title 21, Code of 
Federal Regulations (CFR), notice is hereby given that on January 6, 
2004, Mallinckrodt Inc., Mallinckrodt & Second Streets, St. Louis, 
Missouri 63147, made application by renewal to the Drug Enforcement 
Administration to be registered as an importer of the basic classes of 
controlled substances listed below:

[[Page 12180]]



------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phenylacetone (8501).......................  II
Coca Leaves (9040).........................  II
Raw Opium (9600)...........................  II
Opium poppy (9650).........................  II
Concentrate of Poppy Straw (9670)..........  II
------------------------------------------------------------------------

    The firm plans to import the listed controlled substances to bulk 
manufacture controlled substances.
    Any manufacturer holding, or applying for, registration as a bulk 
manufacturer of the basic classes of controlled substances may file 
written comments on or objections to the application described above 
and may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.43 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed, in quintuplicate, to the Deputy Assistant Administrator, 
Office of Diversion Control, Drug Enforcement Administration, United 
States Department of Justice, Washington, DC 20537, Attention: Federal 
Register Representative, Office of Chief Counsel (CCD) and must be 
filed no later than April 14, 2004. This procedure is to be conducted 
simultaneously with and independent of the procedures described in 21 
CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous 1975 
notice at 40 FR 43745-46 (September 23, 1975), all applicants for 
registration to import basic class of any controlled substance in 
Schedule I or II are and will continue to be required to demonstrate to 
the Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration that the requirements for such registration 
pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42(a), 
(b), (c), (d), (e), and (f) are satisfied.

    Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-5775 Filed 3-12-04; 8:45 am]
BILLING CODE 4410-09-M